Depression Aggravates Immune-Mediated Hepatitis Through NLRP3 Overactivation Induced by Intestinal Microbiota

Area of Science:

• Hepatology
• Immunology
• Microbiology
• Psychiatry

Background:

• Autoimmune hepatitis (AIH) is linked to adverse outcomes in depressed patients, but mechanisms are unclear.
• This study investigates the role of depression and gut microbiota in immune-mediated hepatitis.
• Understanding this link is crucial for managing AIH patients with co-occurring depression.

Purpose of the Study:

• To explore the impact of depression and associated gut microbiota on immune-mediated hepatitis.
• To elucidate the mechanisms linking depression, gut barrier dysfunction, and liver inflammation in AIH.
• To identify potential therapeutic targets for managing AIH in depressed individuals.

Main Methods:

• Assessed depression in 260 AIH patients and 173 controls.
• Induced depressive-like behaviors and hepatitis in mice models.
• Utilized fecal microbiota transplantation (FMT) from patients with major depressive disorder (MDD) and controls.

Main Results:

• Depression affects 40.8% of AIH patients, correlating with cirrhosis.
• Depressed AIH patients exhibit increased intestinal barrier dysfunction and hepatic NLRP3 inflammasome activation.
• Gut bacteria Lactococcus formosensis translocated to the liver, inducing inflammation and injury in mice.

Conclusions:

• Depression exacerbates immune-mediated hepatitis via gut barrier disruption and hepatic NLRP3 inflammasome overactivation.
• Gut-derived L. formosensis contributes to liver injury in mice, suggesting a microbial link.
• Screening AIH patients for depression is essential for comprehensive patient care.